Optimizing viable leukocyte sampling from the female genital tract for clinical trials: An international multi-site study

Lyle R. McKinnon, Sean M. Hughes, Stephen C. De Rosa, Jeffrey A. Martinson, Jill Plants, Kirsten E. Brady, Pamela P. Gumbi, Devin J. Adams, Lucia Vojtech, Christine G. Galloway, Michael Fialkow, Gretchen Lentz, Dayong Gao, Zhiquan Shu, Billy Nyanga, Preston Izulla, Joshua Kimani, Steve Kimwaki, Alfred Bere, Zoe MoodieAlan L. Landay, Jo Ann S. Passmore, Rupert Kaul, Richard M. Novak, M. Juliana McElrath, Florian Hladik

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

Background: Functional analysis of mononuclear leukocytes in the female genital mucosa is essential for understanding the immunologic effects of HIV vaccines and microbicides at the site of HIV exposure. However, the best female genital tract sampling technique is unclear. Methods and Findings: We enrolled women from four sites in Africa and the US to compare three genital leukocyte sampling methods: cervicovaginal lavages (CVL), endocervical cytobrushes, and ectocervical biopsies. Absolute yields of mononuclear leukocyte subpopulations were determined by flow cytometric bead-based cell counting. Of the non-invasive sampling types, two combined sequential cytobrushes yielded significantly more viable mononuclear leukocytes than a CVL (p<0.0001). In a subsequent comparison, two cytobrushes yielded as many leukocytes (∼10,000) as one biopsy, with macrophages/monocytes being more prominent in cytobrushes and T lymphocytes in biopsies. Sample yields were consistent between sites. In a subgroup analysis, we observed significant reproducibility between replicate same-day biopsies (r = 0.89, p = 0.0123). Visible red blood cells in cytobrushes increased leukocyte yields more than three-fold (p = 0.0078), but did not change their subpopulation profile, indicating that these leukocytes were still largely derived from the mucosa and not peripheral blood. We also confirmed that many CD4+ T cells in the female genital tract express the α4β7 integrin, an HIV envelope-binding mucosal homing receptor. Conclusions: CVL sampling recovered the lowest number of viable mononuclear leukocytes. Two cervical cytobrushes yielded comparable total numbers of viable leukocytes to one biopsy, but cytobrushes and biopsies were biased toward macrophages and T lymphocytes, respectively. Our study also established the feasibility of obtaining consistent flow cytometric analyses of isolated genital cells from four study sites in the US and Africa. These data represent an important step towards implementing mucosal cell sampling in international clinical trials of HIV prevention.

Original languageEnglish (US)
Article numbere85675
JournalPloS one
Volume9
Issue number1
DOIs
StatePublished - Jan 15 2014
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Optimizing viable leukocyte sampling from the female genital tract for clinical trials: An international multi-site study'. Together they form a unique fingerprint.

Cite this